These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 21660619
1. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer. Li M, Zhao ZW. Med Oncol; 2012 Jun; 29(2):970-6. PubMed ID: 21660619 [Abstract] [Full Text] [Related]
6. Promoter methylation and immunohistochemical expression of hMLH1 and hMSH2 in sporadic colorectal cancer: a study from India. Malhotra P, Anwar M, Kochhar R, Ahmad S, Vaiphei K, Mahmood S. Tumour Biol; 2014 Apr; 35(4):3679-87. PubMed ID: 24317816 [Abstract] [Full Text] [Related]
7. Mismatch repair gene promoter methylation and expression in hydatidiform moles. Chen H, Ye D, Xie X, Lu W, Zhu C, Chen X. Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238 [Abstract] [Full Text] [Related]
8. Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma. Czerninski R, Krichevsky S, Ashhab Y, Gazit D, Patel V, Ben-Yehuda D. Oral Dis; 2009 Apr; 15(3):206-13. PubMed ID: 19207881 [Abstract] [Full Text] [Related]
9. Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer. Wang Y, Li D, Li X, Teng C, Zhu L, Cui B, Zhao Y, Hu F. Med Oncol; 2014 Jul; 31(7):39. PubMed ID: 24990217 [Abstract] [Full Text] [Related]
10. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer. Ling ZQ, Li P, Ge MH, Hu FJ, Fang XH, Dong ZM, Mao WM. Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174 [Abstract] [Full Text] [Related]
11. Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects. Ashktorab H, Brim H, Al-Riyami M, Date A, Al-Mawaly K, Kashoub M, Al-Mjeni R, Smoot DT, Al-Moundhri M, Al-Hashemi S, Ganguly SS, Raeburn S. Dig Dis Sci; 2008 Oct; 53(10):2723-31. PubMed ID: 18299982 [Abstract] [Full Text] [Related]
12. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S. Cancer; 2007 Feb 15; 109(4):703-12. PubMed ID: 17219447 [Abstract] [Full Text] [Related]
13. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer. Alkam Y, Mitomi H, Nakai K, Himuro T, Saito T, Takahashi M, Arakawa A, Yao T, Saito M. Histopathology; 2013 Nov 15; 63(5):713-25. PubMed ID: 24004112 [Abstract] [Full Text] [Related]
14. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation]. Zhu CK, Ye DF, Xie X, Cheng XD, Chen HZ, Lu WG. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug 15; 25(4):422-6. PubMed ID: 12974087 [Abstract] [Full Text] [Related]
15. Not hMSH2 but hMLH1 is frequently silenced by hypermethylation in endometrial cancer but rarely silenced in pancreatic cancer with microsatellite instability. Kondo E, Furukawa T, Yoshinaga K, Kijima H, Semba S, Yatsuoka T, Yokoyama T, Fukushige S, Horii A. Int J Oncol; 2000 Sep 15; 17(3):535-41. PubMed ID: 10938395 [Abstract] [Full Text] [Related]
16. Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women. Naqvi RA, Hussain A, Deo SS, Kukreti H, Chauhan M, Sarin R, Saxena A, Asim M, Shukla NK, Husain SA, Pasha ST, Basir SF. Hum Pathol; 2008 May 15; 39(5):672-80. PubMed ID: 18329696 [Abstract] [Full Text] [Related]
17. [Expression and significance of mismatch repair genes hMLH1 and hMSH2 in sporadic colorectal carcinoma]. Zheng JY, Ren TS, Liu B, Wang MN, Liao HH. Zhonghua Zhong Liu Za Zhi; 2010 Aug 15; 32(8):590-4. PubMed ID: 21122410 [Abstract] [Full Text] [Related]
18. Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression. Moghbeli M, Moaven O, Memar B, Raziei HR, Aarabi A, Dadkhah E, Forghanifard MM, Manzari F, Abbaszadegan MR. J Gastrointest Cancer; 2014 Mar 15; 45(1):40-7. PubMed ID: 24022108 [Abstract] [Full Text] [Related]
19. Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. Wang YC, Lu YP, Tseng RC, Lin RK, Chang JW, Chen JT, Shih CM, Chen CY. J Clin Invest; 2003 Mar 15; 111(6):887-95. PubMed ID: 12639995 [Abstract] [Full Text] [Related]
20. Head and neck squamous cell carcinoma: mismatch repair immunohistochemistry and promoter hypermethylation of hMLH1 gene. Tawfik HM, El-Maqsoud NM, Hak BH, El-Sherbiny YM. Am J Otolaryngol; 2011 Mar 15; 32(6):528-36. PubMed ID: 21353335 [Abstract] [Full Text] [Related] Page: [Next] [New Search]